Immunic, Inc. Reports First Quarter 2022 Financial Results and Provides Corporate Update ...Middle East

– Top-Line Data from Phase 2 CALDOSE-1 Trial of Vidofludimus Calcium in Moderate-to-Severe Ulcerative Colitis Expected Next Month – – Part C Portion of Phase 1 Trial of IMU-935 in Psoriasis Patients Ongoing; Data Expected in the Second Half of 2022 – – Current Cash and Cash Equivalents...

Hence then, the article about immunic inc reports first quarter 2022 financial results and provides corporate update was published today ( Tuesday 10/05/2022 - 01:51 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Immunic, Inc. Reports First Quarter 2022 Financial Results and Provides Corporate Update )

Also on site :

• ‘The Pitt’ Star Lucas Iverson Breaks Down Ogilvie’s Brutal Wake-Up Call: 'He’s Being Obliterated' (Exclusive)
• Kristen Stewart Tapped to Play '80s Feminist Icon
• Iranian football players celebrated in Tehran